T Naseer, EM Minshall, DY Leung, S Laberge, P Ernst, RJ Martin and Q Hamid
Meakins-Christie Laboratories, Department of Pathology, McGill University, Montreal, Quebec, Canada.

Interleukin-12 (IL-12) and IL-13 are two recently characterized cytokines which play an important role in the induction of T helper cell type 1 (Th1-) and Th2-like cells, respectively. Using the technique of in situ hybridization, we have investigated the expression of these cytokines in bronchial biopsies from nine allergic asthmatics and nine normal control subjects. To determine the effect of steroid therapy on the expression of IL-12 and IL-13 in asthma, the numbers of cells expressing these cytokine mRNA before and after a 1-wk course of oral prednisone in six steroid-sensitive (SS) and five steroid- resistant (SR) moderately severe asthmatics were also examined. There was an increased number of IL-13, and a decreased number of IL-12 mRNA positive cells in asthmatic subjects compared with normal control subjects (p < 0.001). After steroid treatment, the increase in FEV1 values observed in SS asthmatics was accompanied by a significant decrease in cells expressing IL-13 mRNA (p < 0.05) and an increase in the numbers of cells expressing IL-12 mRNA (p < 0.05). In contrast, steroid therapy in SR asthmatics was not associated with significant changes in IL-12 and IL-13 mRNA expression. Thus, allergic asthma is associated with a downregulation of IL-12 mRNA expression and an upregulation of IL-13 mRNA expression. These results suggest an in vivo role for IL-12 and IL-13 in modulating allergic responses and support the notion that the clinical effects of glucocorticoids are at least partially mediated through the modulation of cytokine production.

This article has been cited by other articles:

				J. Shannon, P. Ernst, Y. Yamauchi, R. Olivenstein, C. Lemiere, S. Foley, L. Cicora, M. Ludwig, Q. Hamid, and J. G. Martin Differences in Airway Cytokine Profile in Severe Asthma Compared to Moderate Asthma Chest, February 1, 2008; 133(2): 420 - 426. [Abstract] [Full Text] [PDF]

				E. CALCAGNI and I. ELENKOV Stress System Activity, Innate and T Helper Cytokines, and Susceptibility to Immune-Related Diseases Ann. N.Y. Acad. Sci., June 1, 2006; 1069(1): 62 - 76. [Abstract] [Full Text] [PDF]

				E Truyen, L Coteur, E Dilissen, L Overbergh, L J Dupont, J L Ceuppens, and D M A Bullens Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients Thorax, March 1, 2006; 61(3): 202 - 208. [Abstract] [Full Text] [PDF]

				Y. Miyazaki, H. Inoue, M. Matsumura, K. Matsumoto, T. Nakano, M. Tsuda, S. Hamano, A. Yoshimura, and H. Yoshida Exacerbation of Experimental Allergic Asthma by Augmented Th2 Responses in WSX-1-Deficient Mice J. Immunol., August 15, 2005; 175(4): 2401 - 2407. [Abstract] [Full Text] [PDF]

				P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 184 - 190. [Abstract] [Full Text] [PDF]

				H. W. Chu, S. Balzar, G. J. Seedorf, J. Y. Westcott, J. B. Trudeau, P. Silkoff, and S. E. Wenzel Transforming Growth Factor-{beta}2 Induces Bronchial Epithelial Mucin Expression in Asthma Am. J. Pathol., October 1, 2004; 165(4): 1097 - 1106. [Abstract] [Full Text] [PDF]

				I. J. ELENKOV Glucocorticoids and the Th1/Th2 Balance Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 138 - 146. [Abstract] [Full Text] [PDF]

				N. G. Sandler, M. M. Mentink-Kane, A. W. Cheever, and T. A. Wynn Global Gene Expression Profiles During Acute Pathogen-Induced Pulmonary Inflammation Reveal Divergent Roles for Th1 and Th2 Responses in Tissue Repair J. Immunol., October 1, 2003; 171(7): 3655 - 3667. [Abstract] [Full Text] [PDF]

				J. A. Elias, C. G. Lee, T. Zheng, Y. Shim, and Z. Zhu Interleukin-13 and Leukotrienes: An Intersection of Pathogenetic Schema Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 401 - 404. [Full Text] [PDF]

				M. Inman Do Complex Conditions Require Complex Treatment? Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 6 - 6. [Full Text] [PDF]

				G. W. Wong, P. S. Foster, S. Yasuda, J. C. Qi, S. Mahalingam, E. A. Mellor, G. Katsoulotos, L. Li, J. A. Boyce, S. A. Krilis, et al. Biochemical and Functional Characterization of Human Transmembrane Tryptase (TMT)/Tryptase gamma . TMT IS AN EXOCYTOSED MAST CELL PROTEASE THAT INDUCES AIRWAY HYPERRESPONSIVENESS IN VIVO VIA AN INTERLEUKIN-13/INTERLEUKIN-4 RECEPTOR alpha /SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 6-DEPENDENT PATHWAY J. Biol. Chem., October 25, 2002; 277(44): 41906 - 41915. [Abstract] [Full Text] [PDF]

				S. E. Wenzel, J. B. Trudeau, S. Barnes, X. Zhou, M. Cundall, J. Y. Westcott, K. McCord, and H. W. Chu TGF-{beta} and IL-13 Synergistically Increase Eotaxin-1 Production in Human Airway Fibroblasts J. Immunol., October 15, 2002; 169(8): 4613 - 4619. [Abstract] [Full Text] [PDF]

				D. M. Walter, J. J. McIntire, G. Berry, A. N. J. McKenzie, D. D. Donaldson, R. H. DeKruyff, and D. T. Umetsu Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity J. Immunol., October 15, 2001; 167(8): 4668 - 4675. [Abstract] [Full Text] [PDF]

				E. Nutku, Q. Zhuang, A. Soussi-Gounni, F. Aris, B. D. Mazer, and Q. Hamid Functional Expression of IL-12 Receptor by Human Eosinophils: IL-12 Promotes Eosinophil Apoptosis J. Immunol., July 15, 2001; 167(2): 1039 - 1046. [Abstract] [Full Text] [PDF]

				J.C. Kips Cytokines in asthma Eur. Respir. J., July 2, 2001; 18(34_suppl): 24S - 33s. [Abstract] [Full Text] [PDF]

				J.C. Kips, K.G. Tournoy, and R.A. Pauwels New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5 Eur. Respir. J., March 1, 2001; 17(3): 499 - 506. [Abstract] [Full Text] [PDF]

				S. J. Till, L. A. Jopling, P. A. Wachholz, R. L. Robson, S. Qin, D. P. Andrew, L. Wu, J. van Neerven, T. J. Williams, S. R. Durham, et al. T Cell Phenotypes of the Normal Nasal Mucosa: Induction of Th2 Cytokines and CCR3 Expression by IL-4 J. Immunol., February 15, 2001; 166(4): 2303 - 2310. [Abstract] [Full Text] [PDF]

				M J Plummeridge, L Armstrong, M A Birchall, and A B Millar Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects Thorax, October 1, 2000; 55(10): 842 - 847. [Abstract] [Full Text]

				M. L. KAPSENBERG, C. M. U. HILKENS, T. C. M. T. van der POUW KRAAN, E. A. WIERENGA, and P. KALINSKI Atopic Allergy: A Failure of Antigen-Presenting Cells to Properly Polarize Helper T Cells? Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): S76 - 80. [Full Text] [PDF]

				E. M. Varga, P. Wachholz, K. T. Nouri-Aria, A. Verhoef, C. J. Corrigan, S. J. Till, and S. R. Durham T Cells from Human Allergen-Induced Late Asthmatic Responses Express IL-12 Receptor {beta}2 Subunit mRNA and Respond to IL-12 In Vitro J. Immunol., September 1, 2000; 165(5): 2877 - 2885. [Abstract] [Full Text] [PDF]

				J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]

				P. J. BARNES Endogenous Inhibitory Mechanisms in Asthma Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S176 - 181. [Full Text] [PDF]

				R. A. TAHA, E. M. MINSHALL, R. OLIVENSTEIN, D. IHAKU, B. WALLAERT, A. TSICOPOULOS, A.-B. TONNEL, R. DAMIA, D. MENZIES, and Q. A. HAMID Increased Expression of IL-12 Receptor mRNA in Active Pulmonary Tuberculosis and Sarcoidosis Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1119 - 1123. [Abstract] [Full Text]

				K F Chung and P J Barnes Cytokines in asthma Thorax, September 1, 1999; 54(9): 825 - 857. [Full Text]

				D. A. Schwartz, C. L. Wohlford-Lenane, T. J. Quinn, and A. M. Krieg Bacterial DNA or Oligonucleotides Containing Unmethylated CpG Motifs Can Minimize Lipopolysaccharide-Induced Inflammation in the Lower Respiratory Tract Through an IL-12-Dependent Pathway J. Immunol., July 1, 1999; 163(1): 224 - 231. [Abstract] [Full Text] [PDF]

				K. L. Anderson, P. W. Mathieson, K. M. Gillespie;, M. Wills-Karp, and L. J. Rosenwasser; Polymorphisms Not Found in the IL-13 Gene Promoter Science, May 28, 1999; 284(5419): 1431a - 1431. [Full Text]

				G. Grünig, M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, et al. Requirement for IL-13 Independently of IL-4 in Experimental Asthma Science, December 18, 1998; 282(5397): 2261 - 2263. [Abstract] [Full Text]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				A. Keane-Myers, M. Wysocka, G. Trinchieri, and M. Wills-Karp Resistance to Antigen-Induced Airway Hyperresponsiveness Requires Endogenous Production of IL-12 J. Immunol., July 15, 1998; 161(2): 919 - 926. [Abstract] [Full Text] [PDF]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]